> Studies have shown that Celebrex and statins can halt rising PSA or
> even lower PSA levels in men with recurrent PCa. However, I don't
[quoted text clipped - 3 lines]
> chronic pain to get Celebrex (or other COX-2 inhibitor), but not his
> cholesterol levels to get a statin med. I was just wondering.
I don't think that he can legally prescribe it, but almost every man with
PCa has some arthritis.

Signature
PSA 16 10/17/2000 @ 46
Biopsy 11/01/2000 G7 (3+4), T2c
RRP 12/15/2000 G7 (3+4), T3cN0M0 Neg margins
PSA .1 .1 .1 .27 .37 .75
EBRT 05-07/2002 @ 47
PSA .34 .22 .15 .21 .32
Lupron 07/03 (1 mo) 8/03 (4 mo), 12/03, 4/04, 09/04, 01/05, 5/05, 10/05,
2/06
PSA .07 .05 .06 .09 .08 .132
Non Illegitimi Carborundum
> Studies have shown that Celebrex and statins can halt rising PSA or
> even lower PSA levels in men with recurrent PCa. However, I don't
[quoted text clipped - 3 lines]
> chronic pain to get Celebrex (or other COX-2 inhibitor), but not his
> cholesterol levels to get a statin med. I was just wondering.
Prescribing drugs "off-label", meaning for conditions that are
not approved by the FDA, is perfectly legal. Whether it is
desirable or represents good medicine, is another story.
According to:
http://www.nlm.nih.gov/medlineplus/news/fullstory_33273.html
a study in 2001 looked at 160 prescription drugs and found 21% of
the prescriptions written for them were off-label. Some other
estimates are higher than that.
Drugs may be prescribed off label for any of the following reasons:
1. There is evidence of the drug's efficacy for the particular
off-label use, but it was never submitted to the FDA, which
requires two rigorously conducted clinical trials, with
expensive operating and reporting costs.
2.a. There is no "on-label" drug for the condition. The doctor
is trying to do something for the patient and the only option
is something that is, in a real sense, experimental. The
doctor either reasons that this may help, or has heard from
others that it may help, and feels that he has try to do
something.
2.b. On-label drugs haven't worked. The doctor tried other drugs
without success, presumably including the drugs that are
recommended for this condition. He wants to help. So he
tries something else.
3. The patient demands the drug. This actually occurs a lot.
Patients see ads on TV for some drug for some condition. The
doctor says, "We don't have any evidence that you have that
condition, there's no reason to think this will help you."
But the patient says, "Well I think it might help and I want
it and if you won't give it to me I'll find another doctor who
will." Doctors get tired of hearing that and often just give
in.
The first two reasons seem to be ethical as well as legal.
However the doctor really needs to read the research on the drug
and have at least some good reason to believe the drug will do
more good than harm. I think it is unethical if the doctor
hasn't read up on the drug and satisfied himself that it is
unlikely to harm his patient and may do some good.
The third reason seems to me to be highly questionable. I
understand why it happens. Doctors have a great many ignorant
and/or unreasonable patients. Most people in the U.S. and
elsewhere have only a hazy idea of what science is even about.
[I have even met a doctor like that.]
On the face of it, rising PSA after failed primary treatment
certainly falls into my category "2a" or "2b". If ADT is also
failing, or even if it's not, we don't have a good treatment that
will prevent death in the long run. If there's evidence for
off-label use of drugs, I think I'd be inclined to go for it. If
I were a doctor I might be willing to prescribe it.
As for Celebrex or statins for PCa, I suggest that anyone
considering this should look it up in Pubmed and anyplace else
you can find. Read the research. If it looks positive, print it
out and take it to your doctor to discuss it. Don't just print
out the postive reports. If you find a credible negative report,
print that too.
This won't always be of much use. Some doctors won't read
printouts handed to them by a patient. Some won't read research
at all - they just do what they've always done. But it is
definitely a good idea to discuss any off label use with a
doctor, listen to what he says, and not make demands if he gives
reasonable arguments against doing what you want to do.
Alan
Steve Jordan - 19 May 2006 18:35 GMT
On May 18, Alan Meyer wrote, in pertinent part:
> Prescribing drugs "off-label", meaning for conditions that are
> not approved by the FDA, is perfectly legal. Whether it is
[quoted text clipped - 6 lines]
> estimates are higher than that.
>
(snip excellent and comprehensive review of off-label drug usage)
I am grateful for the time and energy that Alan expended in gathering
information on this important subject.
One current example of widespread off-label prescriptions is Proscar
(finasteride) and the similar Avodart (dutasteride). The "label" use of
these drugs is tx of symptomatic BPH.
But by reason of the fact that they are 5-alpha reductase inhibitors,
they also prevent this enzyme from converting testosterone (T) to the
much more powerful dihydrotestosterone (DHT). Thus to that extent
nourishment of PCa cells is prevented.
These drugs are often used as part of ADT tx and also (as in my case)
used to maintain PCa inhibition when the patient (pt) is in the
off-cycle of intermittent ADT (IADT).
I understand that they also help to grow hair....
> ...............................................................Some doctors won't read
> printouts handed to them by a patient. Some won't read research
[quoted text clipped - 3 lines]
> reasonable arguments against doing what you want to do.
>
I am deeply thankful that my med onc reads what I pass along (mostly
clinical study abstracts), and thanks me for them. She frankly admits
that she simply cannot read everything. On that point, there is an
online medical resource called uptodate.com. It's for medics and
publishes articles that provide information on the latest medical news,
with footnotes. She uses it, as does my PCP. I'd love to subscribe, but
it's $495 annually, a bit steep.
While I'm praising my med onc, I must say that she has done something
I've never heard of: she has given me what I call "homework assignments"
to study and report back on certain topics. Lately, she sent me a
14-page article from uptodate.com, complete with artwork and 40
footnotes, on "Use of Biochemical Markers of Bone Turnover in
Osteoporosis." My assignment: to report back on whether there might be a
better marker than the Pyrilinks-D (deoxypyridinoline) test osteoblastic
(bone mineral destruction) activity.
This is a large job and heavy responsibility. I have to say that I'm
rather flattered. Or is this her revenge for all the questions I ask? Hmmm.
Regards,
Steve J
"Do not go where the path may lead, go instead where there is no path
and leave a trail."
-- Ralph Waldo Emerson